Urologische Klinik und Poliklinik » Forschung » Publikationen 2017

Publikationen 2017

Inhibition of smooth muscle contraction and ARF 6 activity by the inhibitor for cytohesin GEFs, secinH3 in the human prostate.
Am J Physiol Renal Physiol. 2017;
Herlemann A, Keller P, Schott M, Tamalunas A, Ciotkowska A, Rutz B, Wang Y, Yu Q, Waidelich R, Strittmatter F, Stief CG, Gratzke C, Hennenberg M

Micro-endoscopy of the human vas deferens: a feasibility study of a novel device in several ex vivo models.
Andrology. 2017;5(1): 75-81
Trottmann M, Sroka R, Braun C, Liedl B, Schaaf H, Graw M, Becker AJ, Stief CG, Khoder WY

36-month data for the AdVance XP(®) male sling: results of a prospective multicentre study.
BJU Int. 2017;119(4): 626-630
Bauer RM, Grabbert MT, Klehr B, Gebhartl P, Gozzi C, Homberg R, May F, Rehder P, Stief CG, Kretschmer A

Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study.
BJU Int. 2017;119(5): 767-775
Gratzke C, Barber N, Speakman M, Berges R, Wetterauer U, Greene D, Sievert KD, Chapple C, Sonksen J

Long-term kinetics of Zika virus RNA and antibodies in body fluids of a vasectomized traveller returning from Martinique: a case report.
BMC Infect Dis. 2017;17(1): 55
Froeschl G, Huber K, von Sonnenburg F, Nothdurft HD, Bretzel G, Hoelscher M, Zoeller L, Trottmann M, Pan-Montojo F, Dobler G, Woelfel SA

Local epidemiology and resistance profiles in acute uncomplicated cystitis (AUC) in women: a prospective cohort study in an urban urological ambulatory setting.
BMC Infect Dis. 2017;17(1): 685
Seitz M, Stief C, Waidelich R

Preclinical study investigating the potential of low-dose-rate brachytherapy with (32)P stents for the prevention of restenosis of paranasal neo-ostia.
Brachytherapy. 2017;16(1): 207-214
Oestreicher E, Bartsch H, Mayr D, Schubert M, Weber B, Kneschaurek P, Assmann W, Sroka R, Betz CS

Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials-Analyses From the German Clinical RCC Registry.
Clin Genitourin Cancer. 2017;15(2): e209-e215
Marschner N, Staehler M, Müller L, Nusch A, Harde J, Koska M, Jänicke M, Goebell PJ, RCC Registry Group

The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians.
Clin Genitourin Cancer. 2017;15(3): 356-362
Martini T, Gilfrich C, Mayr R, Burger M, Pycha A, Aziz A, Gierth M, Stief CG, Müller SC, Wagenlehner F, Roigas J, Hakenberg OW, Roghmann F, Nuhn P, Wirth M, Novotny V, Hadaschik B, Grimm MO, Schramek P, Haferkamp A, Colleselli D, Kloss B, Herrmann E, Fisch M, May M, Bolenz C

Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
Clin Genitourin Cancer. 2017;
Schulz GB, Grimm T, Buchner A, Jokisch F, Grabbert M, Schneevoigt BS, Kretschmer A, Stief CG, Karl A

Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort.
Clin Genitourin Cancer. 2017;
Vetterlein MW, Meyer CP, Leyh-Bannurah SR, Mayr R, Gierth M, Fritsche HM, Burger M, Keck B, Wullich B, Martini T, Bolenz C, Pycha A, Hanske J, Roghmann F, Noldus J, Bastian PJ, Gilfrich C, May M, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A, PROMETRICS 2011 study group , Bartsch G, Brookman-May S, Buchner A, Durschnabel M, Ellinger J, Froehner M, Georgieva G, Gördük M, Grimm MO, Hadaschik B, Haferkamp A, Hakenberg OW, Hartmann F, Herrmann E, Hertle L, Hohenfellner M, Janetschek G, Kraischits N, Krausse A, Lusuardi L, Michel MS, Moritz R, Müller SC, Novotny V, Nuhn P, Pahernik S, Palisaar RJ, Ponholzer A, Protzel C, Roigas J, Schmid M, Schramek P, Seitz C, Sikic D, Stief CG, Syring I, Vallo S, Wagenlehner FM, Weidner W, Wirth MP

Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.
Curr Opin Urol. 2017;27(3): 205-209
Eapen RS, Herlemann A, Washington SL, Cooperberg MR    

Prostatic Urethral Lift Versus Transurethral Resection of the Prostate (TURP).
Curr Urol Rep. 2017;18(10): 82
Magistro G, Stief CG, Gratzke C

Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region.
Eur J Pharmacol. 2017;
Hennenberg M, Tamalunas A, Wang Y, Keller P, Schott M, Strittmatter F, Herlemann A, Yu Q, Rutz B, Ciotkowska A, Stief CG, Gratzke C

Dual energy CT allows for improved characterization of response to antiangiogenic treatment in patients with metastatic renal cell cancer.
Eur Radiol. 2017;27(6): 2532-2537
Hellbach K, Sterzik A, Sommer W, Karpitschka M, Hummel N, Casuscelli J, Ingrisch M, Schlemmer M, Graser A, Staehler M

Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma.
Eur Urol. 2017;71(5): 719-722
Bex A, Albiges L, Ljungberg B, Bensalah K, Dabestani S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Staehler M, Volpe A, Powles T

A PET for All Seasons: (18)F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?
Eur Urol. 2017;
Fendler WP, Eiber M, Stief CG, Herrmann K

A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma.
Eur Urol. 2017;71(3): 426-436
Fernández-Pello S, Hofmann F, Tahbaz R, Marconi L, Lam TB, Albiges L, Bensalah K, Canfield SE, Dabestani S, Giles RH, Hora M, Kuczyk MA, Merseburger AS, Powles T, Staehler M, Volpe A, Ljungberg B, Bex A

Pathophysiology and Contributing Factors in Postprostatectomy Incontinence: A Review.
Eur Urol. 2017;71(6): 936-944
Heesakkers J, Farag F, Bauer RM, Sandhu J, De Ridder D, Stenzl A

Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy.
Eur Urol. 2017;
Herlemann A, Cowan JE, Carroll PR, Cooperberg MR

Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms.
Eur Urol. 2017;
Magistro G, Chapple CR, Elhilali M, Gilling P, McVary KT, Roehrborn CG, Stief CG, Woo HH, Gratzke C

Systematic Review of the Performance of Noninvasive Tests in Diagnosing Bladder Outlet Obstruction in Men with Lower Urinary Tract Symptoms.
Eur Urol. 2017;71(3): 391-402
Malde S, Nambiar AK, Umbach R, Lam TB, Bach T, Bachmann A, Drake MJ, Gacci M, Gratzke C, Madersbacher S, Mamoulakis C, Tikkinen KA, Gravas S, European Association of Urology Non-neurogenic Male LUTS Guidelines Panel

Re: The Role of Adjuvant Radiotherapy in Pathologically Lymph Node Positive Prostate Cancer.
Eur Urol. 2017;
May M, Stief CG, Brookman-May SD

Updated European Association of Urology Guidelines Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer.
Eur Urol. 2017;
Powles T, Albiges L, Staehler M, Bensalah K, Dabestani S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Fernández-Pello S, Tahbaz R, Volpe A, Ljungberg B, Bex A    

Medical Treatment of Male Lower Urinary Tract Symptoms: Does One Fit All?
Eur Urol. 2017;71(4): 582-583
Rieken M, Gratzke C

Medical Treatment of Nocturia in Men with Lower Urinary Tract Symptoms: Systematic Review by the European Association of Urology Guidelines Panel for Male Lower Urinary Tract Symptoms.
Eur Urol. 2017;
Sakalis VI, Karavitakis M, Bedretdinova D, Bach T, Bosch JLHR, Gacci M, Gratzke C, Herrmann TR, Madersbacher S, Mamoulakis C, Tikkinen KAO, Gravas S, Drake MJ

Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
Eur Urol Focus. 2017;
Capitanio U, Stewart GD, Klatte T, Akdogan B, Roscigno M, Marszalek M, Dell'Oglio P, Zaffuto E, Rodriguez Faba O, Salagierski M, Lingard J, Carini M, Ouzaid I, Mir MC, Montorsi F, Da Pozzo LF, Stief C, Minervini A, Brookman-May SD

Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.
Eur Urol Focus. 2017;
Casuscelli J, Becerra MF, Manley BJ, Zabor EC, Reznik E, Redzematovic A, Arcila ME, Tennenbaum DM, Ghanaat M, Kashan M, Stief CG, Carlo M, Voss MH, Feldman DR, Motzer RJ, Chen Y, Reuter VE, Coleman JA, Russo P, Hsieh JJ, Hakimi AA    

The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis.
Eur Urol Focus. 2017;
Tosco L, Laenen A, Briganti A, Gontero P, Karnes RJ, Bastian PJ, Chlosta P, Claessens F, Chun FK, Everaerts W, Gratzke C, Albersen M, Graefen M, Kneitz B, Marchioro G, Salas RS, Tombal B, Van den Broeck T, Van Der Poel H, Walz J, De Meerleer G, Bossi A, Haustermans K, Van Poppel H, Spahn M, Joniau S, European Multicenter Prostate Cancer Clinical and Translational Research group (EMPaCT)

Recommendations on managing lenvatinib and everolimus in patients with advanced or metastatic renal cell carcinoma.
Expert Opin Drug Saf. 2017;16(12): 1413-1426
Grande E, Glen H, Aller J, Argenziano G, Lamas MJ, Ruszniewski P, Zamorano JL, Edmonds K, Sarker S, Staehler M, Larkin J    

Targeting Moderate and Severe Male Stress Urinary Incontinence With Adjustable Male Slings and the Perineal Artificial Urinary Sphincter: Focus on Perioperative Complications and Device Explantations.
Int Neurourol J. 2017;21(2): 109-115
Kretschmer A, Hüsch T, Thomsen F, Kronlachner D, Obaje A, Anding R, Pottek T, Rose A, Olianas R, Friedl A, Hübner W, Homberg R, Pfitzenmaier J, Queissert F, Naumann CM, Wotzka C, Hofmann T, Seiler R, Haferkamp A, Bauer RM, Debates On Male Incontinence (DOMINO)-Project

Risks and benefits of pelvic lymphadenectomy in octogenarians undergoing radical cystectomy due to urothelial carcinoma of the bladder.
Int Urol Nephrol. 2017;49(12): 2137-2142
Grabbert M, Grimm T, Buchner A, Kretschmer A, Apfelbeck M, Schulz G, Jokisch F, Schneevoigt BS, Stief CG, Karl A

Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship.
Int Urol Nephrol. 2017;49(8): 1311-1318
Lebentrau S, Gilfrich C, Vetterlein MW, Schumacher H, Spachmann PJ, Brookman-May SD, Fritsche HM, Schostak M, Wagenlehner FM, Burger M, May M, MR2 study group , Beiser S, Bernhardt J, Bschleipfer T, Dirik Ö, Geiss J, Hauner K, Hoschke B, Karl T, Kestler A, Klotz T, Kuhl C, Lehsnau M, Macht A, Magistro G, Maurer O, Novotny A, Necknig U, Obermaier R, Promnitz S, Retz M, Scheu C, Scholz C, Stief CG, Truß M

Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.
Int Urol Nephrol. 2017;49(2): 247-254
May M, Protzel C, Vetterlein MW, Gierth M, Noldus J, Karl A, Grimm T, Wullich B, Grimm MO, Nuhn P, Bastian PJ, Roigas J, Hadaschik B, Gilfrich C, Burger M, Fisch M, Brookman-May S, Aziz A, Hakenberg OW, PROMETRICS 2011 Research Group , Bartsch G, Bolenz C, Buchner A, Chun FK, Durschnabel M, Ellinger J, Fritsche HM, Froehner M, Georgieva G, Gilfrich C, Gördük M, Haferkamp A, Hartmann F, Herrmann E, Hohenfellner M, Janetschek G, Keck B, Kraischits N, Krausse A, Lusuardi L, Martini T, Mayr R, Moritz R, Müller SC, Novotny V, Pahernik S, Palisaar RJ, Ponholzer A, Pycha A, Rink M, Roghmann F, Schmid M, Schramek P, Seitz C, Shariat SF, Sikic D, Stief CG, Syring I, Vallo S, Wagenlehner FM, Wirth MP

[Urinary tract infections : What has been confirmed in therapy?]
Internist (Berl). 2017;58(12): 1242-1249
Marcon J, Stief CG, Magistro G

Confocal laser endomicroscopy in head and neck malignancies using FITC-labelled EpCAM- and EGF-R-antibodies in cell lines and tumor biopsies.
J Biophotonics. 2017;
Englhard AS, Palaras A, Volgger V, Stepp H, Mack B, Libl D, Gires O, Betz CS

Remission spectrometry for blood vessel detection during stereotactic biopsy of brain tumors.
J Biophotonics. 2017;10(8): 1080-1094
Markwardt NA, Stepp H, Franz G, Sroka R, Goetz M, Zelenkov P, Rühm A

(68)Ga-PSMA-11 PET/CT interobserver agreement for prostate cancer assessments: an international multicenter prospective study.
J Nucl Med. 2017;
Fendler WP, Calais J, Allen-Auerbach M, Bluemel C, Eberhardt N, Emmett L, Gupta P, Hartenbach M, Hope TA, Okamoto S, Pfob CH, Pöppel TD, Rischpler C, Schwarzenböck S, Stebner V, Unterrainer M, Zacho HD, Maurer T, Gratzke C, Crispin A, Czernin J, Herrmann K, Eiber M

A prospective randomised comparison between the transperitoneal and retroperitoneoscopic approaches for robotic-assisted pyeloplasty in a single surgeon, single centre study.
J Robot Surg. 2017;
Khoder WY, Waidelich R, Ghamdi AMA, Schulz T, Becker A, Stief CG

Prognostic Features for Objectively Defined Urinary Continence after Radical Cystectomy and Ileal Orthotopic Neobladder in a Contemporary Cohort.
J Urol. 2017;197(1): 210-215
Kretschmer A, Grimm T, Buchner A, Grimm J, Grabbert M, Jokisch F, Schneevoigt BS, Apfelbeck M, Schulz G, Bauer RM, Stief CG, Karl A

Re: Robotic versus Open Prostatectomy: End of the Controversy: M. O. Koch J Urol 2016;196:9-10.
J Urol. 2017;197(3 Pt 1): 820-821
Stief C, Gleave M

Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial.
JAMA Oncol. 2017;3(7): 913-920
Chamie K, Donin NM, Klöpfer P, Bevan P, Fall B, Wilhelm O, Störkel S, Said J, Gambla M, Hawkins RE, Jankilevich G, Kapoor A, Kopyltsov E, Staehler M, Taari K, Wainstein AJ, Pantuck AJ, Belldegrun AS

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.
Lancet Oncol. 2017;18(2): 181-191
Azzouzi AR, Vincendeau S, Barret E, Cicco A, Kleinclauss F, van der Poel HG, Stief CG, Rassweiler J, Salomon G, Solsona E, Alcaraz A, Tammela TT, Rosario DJ, Gomez-Veiga F, Ahlgren G, Benzaghou F, Gaillac B, Amzal B, Debruyne FM, Fromont G, Gratzke C, Emberton M, PCM301 Study Group

Intraoperative assessment of laryngeal pathologies with optical coherence tomography integrated into a surgical microscope.
Lasers Surg Med. 2017;49(5): 490-497
Englhard AS, Betz T, Volgger V, Lankenau E, Ledderose GJ, Stepp H, Homann C, Betz CS

Photodynamic diagnosis with 5-aminolevulinic acid for intraoperative detection of peritoneal metastases of ovarian cancer: A feasibility and dose finding study.
Lasers Surg Med. 2017;49(2): 169-176
Hillemanns P, Wimberger P, Reif J, Stepp H, Klapdor R

Laser-assisted fixation of a nitinol stapes prosthesis.
Lasers Surg Med. 2017;
Schrötzlmair F, Suchan F, Pongratz T, Krause E, Müller J, Sroka R

[Male urinary incontinence - causes and therapeutic approaches for male stress incontinence].
MMW Fortschr Med. 2017;159(19): 52-56
Grabbert MT, Kretschmer A, Stief C, Bauer R

[Prostate Cancer - Update 2017].
MMW Fortschr Med. 2017;159(4): 58-65
Herlemann A, Kretschmer A, Apfelbeck M, Tritschler S, Fendler W, Bartenstein P, Reiser M, Stief CG, Gratzke C

[Management of benign prostatic hyperplasia (BPH)].
MMW Fortschr Med. 2017;159(9): 58-64
Jokisch JF, Herlemann A, Weinhold P, Magistro G, Stief CG, Gratzke C

Blasenschwäche: Was Sie als Hausarzt wissen sollten.
MMW Fortschr Med. 2017;159(19): 48
Stief C, Mahner S

Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas.
Neurosurgery. 2017; 81(2): 230-239
Stummer W, Stepp H, Wiestler OD, Pichlmeier U

Transient receptor potential a1 (TRPA1) agonists inhibit contractions of the isolated human ureter.
Neurourol Urodyn. 2017;
Weinhold P, Hennenberg M, Strittmatter F, Stief CG, Gratzke C, Hedlund P

Preliminary experience with dosimetry, response and patient reported outcome after 177Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer.
Oncotarget. 2017;8(2): 3581-3590
Fendler WP, Reinhardt S, Ilhan H, Delker A, Böning G, Gildehaus FJ, Stief C, Bartenstein P, Gratzke C, Lehner S, Rominger A

Salvage lymph node dissection after 68Ga-PSMA or 18F-FEC PET/CT for nodal recurrence in prostate cancer patients.
Oncotarget. 2017;8(48): 84180-84192
Herlemann A, Kretschmer A, Buchner A, Karl A, Tritschler S, El-Malazi L, Fendler WP, Wenter V, Ilhan H, Bartenstein P, Stief CG, Gratzke C

Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy.
Oncotarget. 2017;8(27): 44131-44140
Wenter V, Herlemann A, Fendler WP, Ilhan H, Tirichter N, Bartenstein P, Stief CG, la Fougère C, Albert NL, Rominger A, Gratzke C

The high-pathogenicity island (HPI) promotes flagellum-mediated motility in extraintestinal pathogenic Escherichia coli.
PLoS ONE. 2017;12(10): e0183950
Magistro G, Magistro C, Stief CG, Schubert S

Protoporphyrin IX fluorescence as potential indicator of psoriasis severity and progression.
Photodiagnosis Photodyn Ther. 2017;
Wang B, Xu YT, Zhang L, Zheng J, Sroka R, Wang HW, Wang XL

Non-Adrenergic, Tamsulosin-Insensitive Smooth Muscle Contraction is Sufficient to Replace alpha1 -Adrenergic Tension in the Human Prostate.
Prostate. 2017;
Hennenberg M, Acevedo A, Wiemer N, Kan A, Tamalunas A, Wang Y, Yu Q, Rutz B, Ciotkowska A, Herlemann A, Strittmatter F, Stief CG, Gratzke C

The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer.
Prostate Cancer Prostatic Dis. 2017;
Tosco L, Laenen A, Briganti A, Gontero P, Karnes RJ, Albersen M, Bastian PJ, Chlosta P, Claessens F, Chun FK, Everaerts W, Gratzke C, Graefen M, Kneitz B, Marchioro G, Salas RS, Tombal B, Van den Broeck T, Moris L, Battaglia A, van der Poel H, Walz J, Bossi A, De Meerleer G, Haustermans K, Van Poppel H, Spahn M, Joniau S

Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis.
Radiat Oncol. 2017;12(1): 2
Hegemann NS, Schlesinger-Raab A, Ganswindt U, Hörl C, Combs SE, Hölzel D, Gschwend JE, Stief C, Belka C, Engel J

Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy.
Radiat Oncol. 2017;12(1): 176
Schmidt-Hegemann NS, Fendler WP, Buchner A, Stief C, Rogowski P, Niyazi M, Eze C, Li M, Bartenstein P, Belka C, Ganswindt U

Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stage.
Scand J Urol. 2017;51(2): 130-136
Buchner A, Grimm T, Schneevoigt BS, Wittmann G, Kretschmer A, Jokisch F, Grabbert M, Apfelbeck M, Schulz G, Gratzke C, Stief CG, Karl A

Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project).
Scand J Urol. 2017;51(4): 269-276
May M, Surcel C, Capitanio U, Dell'Oglio P, Klatte T, Shariat S, Ecke T, Wolff I, Vergho D, Wagener N, Huck N, Pahernik S, Zastrow S, Wirth M, Borgmann H, Haferkamp A, Musquera M, Krabbe LM, Herrmann E, Scavuzzo A, Mirvald C, Hutterer G, Zigeuner R, Stief CG, Waidelich R, Cindolo L, Kalusova K, Brookman-May SD, Collaborative Research On Renal Neoplasms Association (CORONA) and European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer

Volumetric Optoacoustic Temperature Mapping in Photothermal Therapy.
Sci Rep. 2017;7(1): 9695
Landa FJO, Deán-Ben XL, Sroka R, Razansky D

Effects of Elevated beta-Estradiol Levels on the Functional Morphology of the Testis - New Insights.
Sci Rep. 2017;7: 39931
Leavy M, Trottmann M, Liedl B, Reese S, Stief C, Freitag B, Baugh J, Spagnoli G, Kölle S

A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-beta1 and IL-35.
Sci Rep. 2017;7(1): 3974
Li M, Eckl J, Geiger C, Schendel DJ, Pohla H

Comparison of prostate positioning guided by three-dimensional transperineal ultrasound and cone beam CT.
Strahlenther Onkol. 2017;193(3): 221-228
Li M, Ballhausen H, Hegemann NS, Reiner M, Tritschler S, Gratzke C, Manapov F, Corradini S, Ganswindt U, Belka C

Intraoperative near-infrared autofluorescence imaging of parathyroid glands.
Surg Endosc. 2017;31(8): 3140-3145
Ladurner R, Sommerey S, Arabi NA, Hallfeldt KK, Stepp H, Gallwas JK

Contrast-Enhanced Ultrasonography (CEUS) Reveals Active Bleeding into the Urinary Bladder in a Patient with Bladder Tamponade.
Ultraschall Med. 2017;
Nörenberg D, Mueller-Peltzer K, Tritschler S, Reiser M, Clevert DA

68Gallium-Prostate-Specific Membrane Antigen PET/Computed Tomography for Primary and Secondary Staging in Prostate Cancer.
Urol Clin North Am. 2017;44(4): 557-563
Chaloupka M, Herlemann A, D'Anastasi M, Cyran CC, Ilhan H, Gratzke C, Stief CG

Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier.
Urol Clin North Am. 2017;44(4): 547-555
Herlemann A, Washington SL, Eapen RS, Cooperberg MR

The TiLOOP® Male Sling: Did We Forejudge?
Urol Int. 2017;
Hüsch T, Kretschmer A, Thomsen F, Kronlachner D, Kurosch M, Obaje A, Anding R, Kirschner-Hermanns R, Pottek T, Rose A, Olianas R, Friedl A, Hübner W, Homberg R, Pfitzenmaier J, Grein U, Queissert F, Naumann CM, Schweiger J, Wotzka C, Nyarangi-Dix J, Brehmer B, Ulm K, Bauer RM, Haferkamp A, Debates On Male Incontinence (DOMINO)-Project 8

Risk Factors for Failure of Male Slings and Artificial Urinary Sphincters: Results from a Large Middle European Cohort Study.
Urol Int. 2017;99(1): 14-21
Hüsch T, Kretschmer A, Thomsen F, Kronlachner D, Kurosch M, Obaje A, Anding R, Pottek T, Rose A, Olianas R, Friedl A, Hübner W, Homberg R, Pfitzenmaier J, Grein U, Queissert F, Naumann CM, Schweiger J, Wotzka C, Nyarangi-Dix J, Hofmann T, Ulm K, Bauer RM, Haferkamp A, Debates on Male Incontinence (DOMINO)-Project

Morphological Characterization of Papillary Renal Cell Carcinoma Type 1, the Efficiency of Its Surgical Treatment.
Urol Int. 2017;98(2): 148-155
Procházková K, Staehler M, Trávní?ek I, Pitra T, Eret V, Ürge T, Eberlová L, Rou?arová M, Ho?ek P, Chudá?ek Z, Ferda J, Hes O, Hora M

Clinical Usage of Different Guidelines in Routine Management, Therapy and Follow-Up of Patients with Renal Cell Cancer in Germany.
Urol Int. 2017;98(2): 156-161
Spek A, Szabados B, Ziegelmüller B, Stief C, D'Anastasi M, Staehler M

Follow-up of high-risk bladder cancer-Is it safe to perform fluorescence endoscopy multiple times in the same patient?
Urol Oncol. 2017;
Apfelbeck M, Grimm T, Kretschmer A, Buchner A, Schneevoigt BS, Jokisch F, Grabbert M, Schulz G, Stief CG, Karl A

[Diagnostic workup of urethral strictures].
Urologe A. 2017;
Chaloupka M, Beck V, Kretschmer A, Tritschler S, Stief CG, Strittmatter F

[Cytoreductive, radical prostatectomy in metastatic prostate cancer].
Urologe A. 2017;56(11): 1430-1434
Chaloupka M, Herlemann A, Spek A, Gratzke C, Stief C

[Current treatment of advanced prostate cancer].
Urologe A. 2017;56(11): 1381-1382
Gratzke C, Stief CG

[Primary prostatic sarcoma - a rare malignancy].
Urologe A. 2017;
Herlemann A, Horst D, D'Anastasi M, Kretschmer A, Stief CG, Gratzke C

[Molecular biomarkers and prognostic factors for prostate cancer].
Urologe A. 2017;56(7): 933-944
Kretschmer A, Tolkach Y, Ellinger J, Kristiansen G

[When is surgical treatment indicated in metastatic prostate cancer and what is the scientific rationale?]
Urologe A. 2017;
Kretschmer A, Herlemann A, Stief CG, Gratzke C

[Current EAU guidelines, practice-relevant knowledge, and not a discussion of scientific hypotheses].
Urologe A. 2017;
Lellig E, Apfelbeck M, Straub J, Karl A, Tritschler S, Stief CG, Riccabona M

[Urinary tract infections in children].
Urologe A. 2017;56(2): 247-262
Lellig E, Apfelbeck M, Straub J, Karl A, Tritschler S, Stief CG, Riccabona M

[Pathogenesis of urinary tract infections : An update].
Urologe A. 2017;56(6): 720-727
Magistro G, Marcon J, Schubert S, Gratzke C, Stief CG

[MRI of the prostate].
Urologe A. 2017;56(5): 665-677
Nörenberg D, Solyanik O, Schlenker B, Magistro G, Ertl-Wagner B, Clevert DA, Stief C, Reiser MF, D'Anastasi M

[Imaging of locally advanced prostate cancer : Importance of ultrasound and especially MRI].
Urologe A. 2017;56(11): 1383-1393
Solyanik O, Schlenker B, Gratzke C, Ertl-Wagner B, Clevert DA, Stief C, Ricke J, Nörenberg D

[Radical prostatectomy as part of a multimodal concept for patients with prostate cancer and bone metastases at initial diagnosis].
Urologe A. 2017;
Spek A, Herlemann A, Gratzke C, Stief CG

[Metastasized urological malignancies : Is resection of the primary tumor or destruction using alternative procedures worthwhile?]
Urologe A. 2017;
Stief CG, Rübben H

[Urethral stricture : From diagnostics to appropriate treatment].
Urologe A. 2017;56(8): 1047-1057
Strittmatter F, Beck V, Stief CG, Tritschler S

[Imaging of locally advanced prostate cancer : Importance of ultrasound and especially MRI].
Urologe A. 2017;56(11): 1383-1393
Solyanik O, Schlenker B, Gratzke C, Ertl-Wagner B, Clevert DA, Stief C, Ricke J, Nörenberg D

TOP2A, HELLS, ATAD2, and TET3 Are Novel Prognostic Markers in Renal Cell Carcinoma.
Urology. 2017; 102: 265.e1-265.e7
Chen D, Maruschke M, Hakenberg O, Zimmermann W, Stief CG, Buchner A

Antibiotic Coating of the Artificial Urinary Sphincter (AMS 800(®)): is It Worthwhile?
Urology. 2017;
Hüsch T, Kretschmer A, Thomsen F, Kronlachner D, Kurosch M, Obaje A, Anding R, Pottek T, Rose A, Olianas R, Friedl A, Hübner W, Homberg R, Pfitzenmaier J, Grein U, Queissert F, Naumann CM, Schweiger J, Wotzka C, Nyarangi-Dix J, Hofmann T, Ulm K, Bauer RM, Haferkamp A, Debates On Male Incontinence (DOMINO)-Project

Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter Study.
Urology. 2017;109: 107-114
Wolff I, Scavuzzo A, Capitanio U, Klatte T, Shariat SF, Wagener N, Zastrow S, Borgmann H, Krabbe LM, Hutterer G, May M, Brookman-May SD, Collaborative Research On Renal Neoplasms Association (CORONA) and the European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Ca , Cindolo L, Ecke T, Haferkamp A, Herrmann E, Hohenfellner M, Hora M, Hoschke B, Huck N, Rios MAJ, Mirvald C, Musquera M, Dell'Oglio P, Pahernik S, Prochazkova K, Reynoso-Noverón N, Stief CG, Surcel C, Vergho D, Waidelich R, Wirth M, Zigeuner R

Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients.
World J Urol. 2017;35(12): 1891-1897
Borgmann H, Musquera M, Haferkamp A, Vilaseca A, Klatte T, Shariat SF, Scavuzzo A, Jimenez Rios MA, Wolff I, Capitanio U, Dell'Oglio P, Krabbe LM, Herrmann E, Ecke T, Vergho D, Huck N, Wagener N, Pahernik S, Zastrow S, Wirth M, Surcel C, Mirvald C, Prochazkova K, Hutterer G, Zigeuner R, Cindolo L, Hora M, Stief CG, May M, Brookman-May SD

Postoperative upgrading of prostate cancer in men >=75 years: a propensity score-matched analysis.
World J Urol. 2017;
Herlemann A, Buchner A, Kretschmer A, Apfelbeck M, Stief CG, Gratzke C, Tritschler S

"Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).
World J Urol. 2017;
Herlemann A, Wegner K, Roosen A, Buchner A, Weinhold P, Bachmann A, Stief CG, Gratzke C, Magistro G

Perioperative patient education improves long-term satisfaction rates of low-risk prostate cancer patients after radical prostatectomy.
World J Urol. 2017;35(8): 1205-1212
Kretschmer A*, Buchner A*, Grabbert M, Sommer A, Herlemann A, Stief CG, Bauer R (*co-first authorship)

Prospective evaluation of health-related quality of life after radical cystectomy: focus on peri- and postoperative complications.
World J Urol. 2017;35(8): 1223-1231
Kretschmer A, Grimm T, Buchner A, Grabbert M, Jokisch F, Schneevoigt BS, Apfelbeck M, Schulz G, Stief CG, Karl A

Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.
World J Urol. 2017;35(2): 245-250
May M, Fritsche HM, Vetterlein MW, Bastian PJ, Gierth M, Nuhn P, Aziz A, Fisch M, Stief CG, Hohenfellner M, Wirth MP, Novotny V, Hakenberg OW, Noldus J, Gilfrich C, Bolenz C, Burger M, Brookman-May SD, PROMETRICS 2011 Research Group , Bartsch G, Bolenz C, Buchner A, Chun F, Dahlem R, Durschnabel M, Ellinger J, Froehner M, Georgieva G, Gördük M, Grimm M, Grimm T, Hadaschik B, Haferkamp A, Hartmann F, Herrmann E, Janetschek G, Karl A, Keck B, Kraischits N, Krausse A, Lusuardi L, Martini T, Mayr R, Michel M, Moritz R, Müller S, Nuhn P, Pahernik S, Palisaar R, Ponholzer A, Protzel C, Pycha A, Rink M, Roghmann F, Roigas J, Schmid M, Schramek P, Seitz C, Shariat S, Sikic D, Syring I, Vallo S, Wagenlehner F, Wullich B

Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem.
World J Urol. 2017;
Seitz M, Stief C, Waidelich R, Bader M, Tilki D

Induction of porcine-specific regulatory T cells with high specificity and expression of IL-10 and TGF-?1 using baboon-derived tolerogenic dendritic cells.
Xenotransplantation. 2017;
Li M, Eckl J, Abicht JM, Mayr T, Reichart B, Schendel DJ, Pohla H